Tectonic Therapeutic, Inc. (TECX) Stock Analysis

Tectonic Therapeutic, Inc. (TECX) is a publicly traded company in the HEALTHCARE sector. It trades at $27.43, carries a market capitalization of $545.13M. This page summarizes the public market data, fundamentals, and frequently asked questions for TECX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $27.43
• Market Cap: $545.13M
• EPS: $-4.46
• 52-Week High: $36.03
• 52-Week Low: $14.38

About Tectonic Therapeutic, Inc.

Tectonic Therapeutic, Inc. is an innovative biopharmaceutical company focused on the discovery and development of antibody-based therapies targeting G-protein-coupled receptors (GPCRs), which are crucial in a wide range of diseases. Headquartered in Watertown, Massachusetts, the company aims to address unmet medical needs by creating novel treatment options for patients who have not responded adequately to existing therapies. Through its cutting-edge research and development efforts, Tectonic...

GNG Research Analysis

GNG Research scores Tectonic Therapeutic, Inc. (TECX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for TECX.

Frequently Asked Questions

Does TECX pay dividends?

Tectonic Therapeutic, Inc. (TECX) does not currently pay a regular dividend.

What is TECX's market cap?

Tectonic Therapeutic, Inc. (TECX) has a market capitalization of $545.13M with a current stock price of $27.43.